GlaxoSmithKline AB

Reportlinker Adds Hot Beverages- 2009 Edition.
PR Newswire; 11/12/2009; 3694 words; ...Bassett, the brand leader in chocolate products with its Cadbury's range; GlaxoSmithKline (GSK), which is dominant in malted drinks, with its Horlicks products; and AB Foods' Twinings, the major player in chocolate malted drinks, with its...

Other News To Note.
BIOWORLD Today; 11/4/2009; 3680 words; ...another in-house formulation technology. (See BioWorld Today, Feb. 20, 2003.) o Biovitrum AB, of Stockholm, Sweden, and GlaxoSmithKline plc, of London, agreed to halt a Phase IIb study of BVT.933, a 5-HT2c receptor agonist compound...

Medivir, GSK Agree To EUR86M Deal For Phase I HIV Candidate.
BIOWORLD Today; 11/4/2009; 1039 words; ...International Correspondent Medivir AB last week entered its largest drug...pact worth up to C86 million with GlaxoSmithKline plc to develop its HIV drug MIV...pharmaceutical products subsidiary, CCS AB, is cash-flow positive and prospects...

Medivir, Boehringer Ingelheim Enter Potential EUR122M Alliance.
BIOWORLD Today; 11/4/2009; 1226 words; ...BioWorld Today Correspondent As he put it himself, Medivir AB CEO Lars Adlersson had "two reasons to celebrate" Tuesday...develop MIV-210 the company entered with London-based GlaxoSmithKline plc less than two months ago. Both involve a nucleoside reverse...

Arena's Obesity Drug Positive In First-Look Phase II Results.
BIOWORLD Today; 11/3/2009; 1296 words; ...has proved especially alluring. In the fall of 2002, Stockholm, Sweden-based Biovitrum AB inked a potential $150 million deal with GlaxoSmithKline plc, of London, to develop the former's 5-HT2C receptor agonists for that indication...